Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Cantor Fitzgerald
Moodys
US Army
Argus Health

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 9,499,622

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,499,622
Title:Anti-EGFR/anti-HER2 bispecific antibodies with anti-EGFR DARPins
Abstract: An anti-EGFR/anti-HER2 bispecific antibody including an anti-EGFR DARPin and an anti-HER2 antibody, a pharmaceutical composition including the bispecific antibody, a method of preparing the bispecific antibody, and a method of reducing a side effect and/or enhancing efficacy of an anti-HER2 antibody using an anti-EGFR DARPin.
Inventor(s): Cheong; Kwang Ho (Seoul, KR), Lee; Seung Hyun (Suwon-si, KR), Lin; Powei (Hwaseong-si, KR), Lee; Saet Byoul (Seoul, KR), Hwang; Jae Woong (Seoul, KR)
Assignee: SAMSUNG ELECTRONICS CO., LTD. (Suwon-Si, KR)
Application Number:14/625,296
Patent Claims:see list of patent claims

Details for Patent 9,499,622

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up SAMSUNG ELECTRONICS CO., LTD. (Suwon-Si, KR) 2034-02-18 RX Orphan search
Genentech PERJETA pertuzumab VIAL; SINGLE-USE 125409 001 2012-06-08 ➤ Sign Up SAMSUNG ELECTRONICS CO., LTD. (Suwon-Si, KR) 2034-02-18 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
McKinsey
Federal Trade Commission
US Army
Citi
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.